20:37 31/10/2014 Op-Ed: Pfizer Inc. is active, vital, taxpaying part of Eastern Connecticut
Op-Ed: Pfizer Inc. is active, vital, taxpaying part of Eastern Connecticut
The CT Mirror - 4 hours ago
The Chamber of Commerce of Eastern Connecticut would like to set the record straight regarding Pfizer Inc.'s presence and future in southeastern Connecticut.

11:48 31/10/2014 Drug firm Pfizer gets Bombay High Court nod for merger of Wyeth Ltd
Drug firm Pfizer gets Bombay High Court nod for merger of Wyeth Ltd
Economic Times - 12 hours ago
NEW DELHI: Drug firm Pfizer today said the Bombay High Court has approved the amalgamation of Wyeth Ltd with the company. "The Hon'ble High Court of Judicature at Bombay on October 31, 2014 considered and approved the amalgamation of Wyeth Ltd ...

19:11 29/10/2014 UPDATE 2-Pfizer meningitis vaccine wins US approval
UPDATE 2-Pfizer meningitis vaccine wins US approval
Reuters - Oct 29, 2014
Oct 29 (Reuters) - Pfizer Inc has won U.S. approval for its Trumenba vaccine against meningitis B, a potentially deadly bacterial disease that has recently caused outbreaks on college campuses, the U.S.
Pfizers Trumenba Gains Accelerated Approval in the U.S. - Zacks.com

10:51 29/10/2014 Pfizer Inc.'s Earnings: Emerging Market Growth and Patent Expirations Square Off
Pfizer Inc.'s Earnings: Emerging Market Growth and Patent Expirations Square Off
Motley Fool - Oct 29, 2014
Having lost Lipitor, Viagra, and a number of other key therapies to generic competition in recent years, CEO Ian Read and Pfizer have made it clear that the company plans to grow its business organically and through acquisitions in order to get past ...
Pfizer CEO: still exploring 'tax inversion' tactic - Philly.com
Pfizer Hasn't Ruled Out Potential Inversions, Chief Says - Wall Street Journal

3:56 29/10/2014 New tax rules won't stop Pfizer from moving abroad
New tax rules won't stop Pfizer from moving abroad
Boston Globe - Oct 29, 2014
NEW YORK - The US attempt to block companies from leaving the country for tax reasons would not stop Pfizer Inc. from moving America's biggest drug maker overseas if it finds an attractive deal, chief executive Ian Read said.

13:30 28/10/2014 Stocks to Watch: Pfizer, DuPont, Whirlpool
Stocks to Watch: Pfizer, DuPont, Whirlpool
Wall Street Journal (blog) - Oct 28, 2014
Among the companies with shares expected to actively trade in Tuesday's session are Pfizer Inc., DuPont Co. and Whirlpool Corp.

15:33 27/10/2014 Pfizer (PFE) Stock Falls After Dropping Pain Drug
Pfizer (PFE) Stock Falls After Dropping Pain Drug
TheStreet.com - Oct 27, 2014
NEW YORK (TheStreet) -- Shares of Pfizer Inc. (PFE) are down by 0.21% to $29.05 after the pharmaceutical company notified Pain Therapeutics, Inc. (PTIE) that it has decided to discontinue its agreement to develop and commercialize Remoxy ...
Pfizer to discontinue agreement on remoxy (oxycodone) capsules CII - pharmabiz.com
Intraday Movers: Pain Therapeutics, Inc. (PTIE), Dynavax Technologies ... - Techsonian (press release)

21:35 23/10/2014 Pfizer Approves $11B Stock Repurchase Plan
Pfizer Approves $11B Stock Repurchase Plan
ABC News - Oct 23, 2014
Pfizer Inc. is the world's second-largest drugmaker, and its products include the vaccine Prevnar and pain and fibromyalgia treatment Lyrica.
Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra - 24/7 Wall St.
Pfizer (PFE) $11 Billion Stock Repurchase Plan May End AstraZeneca (AZN) Bid - TheStreet.com

13:56 20/10/2014 Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
Motley Fool - Oct 20, 2014
Big Pharma is undergoing a radical face-lift due to the avalanche of top-selling drugs losing patent protection. The consequences of the aptly named "patent cliff" have been widespread and immense in scope.

13:30 07/10/2014 Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
Motley Fool - Oct 7, 2014
PCSK9 inhibitors, and their potential sales, have garnered a lot of interest from investors Pfizer's (NYSE: PFE ) Lipitor peaked at well over $10 billion in annual sales.